FY21e Ebitda up 14% given positive guidance; ‘Hold’ retained with TP of Rs 200
Management have maintained their debt reduction commitment with a target to bring down debt to Rs 250bn in the next…
Profit met expectations; health remains top-line driver; downgraded to ‘Reduce’ with TP revised to Rs 1,040 from Rs 1,027
In June 2020, daily average card spend in the retail and corporate segments reached 81% and 55% of pre-Covid-19 levels,…
Owing to consumer preferences for safer, trusted branded packaged food products amid the COVID-19 pandemic and Britannia’s sharp execution and…
Growth outlook remains fuzzy; FY21e EPS up c5% given rise in Ebit margin estimate; ‘Hold’ retained with TP going up…
While quarter is likely to be weak, FY21 estimates up 8% given upside risk to guidance; ‘Buy’ maintained.
Given debt levels, deleveraging by company is expected to drive stock movement; ‘Buy’ retained with TP of Rs 66.
Covid-19 poses near-term challenges; downgraded to Hold with revised TP of Rs 475
Despite lockdown, JSP reported 5% y-o-y production growth in April 2020. The company also posted massive 28% y-o-y growth in…
SRCM’s is the most costly cement stock globally; excessive optimism built into key valuation drivers; ‘Reduce’ maintained
Going concern moving slowly; -29/15% change in FY21/22e Ebitda; rating downgraded to ‘Hold’.
Income reversal, provisions hit profit; -5/2% change in FY21/22 PAT; ‘Buy’ retained given franchise strength.
FY21/22e earnings cut by ~8% due to present crisis; TP lowered to Rs 3,500; growth story is intact; ‘Buy’ retained
Cipla saw a sales impact of Rs 200 crore in Q4FY20 (~5% of total sales) due to challenges in the…
Q4 saw a slight miss on margins; FY21/22e EPS cut by 30/11% to factor in Covid-19; TP reduced to Rs…
Subdued performance continues, the key issue for GCPL has been that its operating performance in almost all geographies (barring sequential…
Covid-19 related provisions impacted PAT; there’s relative comfort on asset quality; FY21-22e PAT up 2-3%; TP revised to Rs 415
